(Q40030262)

English

Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus

scientific article published on 3 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

based on heuristic

inferred from title

encephalomyocarditis virus

object named as

encephalomyocarditis virus

1 reference

based on heuristic

inferred from title

author name string

Zhenhai Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Xin Guo

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Xinna Ge

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hong Jia

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hanchun Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

0 references

publication date

3 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

573-580

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Fatal Disease of Swine Due to Encephalomyocarditis Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Transmission of encephalomyocarditis virus in pigs estimated from field data in Belgium by means of R0.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Persistence of encephalomyocarditis virus (EMCV) infection in piglets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Reproductive failure in sows following experimental infection with a Belgian EMCV isolate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Reproductive failure in pigs caused by encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Encephalomyocarditis virus infection of pigs. 1. An outbreak in New South Wales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Comparison of the pathogenic, antigenic and molecular characteristics of two encephalomyocarditis virus (EMCV) isolates from Belgium and Greece

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Outbreaks in Quebec pig farms of respiratory and reproductive problems associated with encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

The occurrence of encephalomyocarditis virus (EMCV) in European pigs from 1990 to 2001

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Factors related to the incidence of clinical encephalomyocarditis virus (EMCV) infection on Belgian pig farms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Transmission of porcine encephalomyocarditis virus (EMCV) to mice by transplanting EMCV-infected pig tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Genetic variability of encephalomyocarditis virus (EMCV) isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

The efficacy of an experimental oil-adjuvanted encephalomyocarditis vaccine in elephants, mice and pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Enhancement of VP1-specific immune responses and protection against EMCV-K challenge by co-delivery of IL-12 DNA with VP1 DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guérin in susceptible mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Cloning and expression of the VP1 major capsid protein of diabetogenic encephalomyocarditis (EMC) virus and prevention of EMC virus-induced diabetes by immunization with the recombinant VP1 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Genomic analysis of two porcine encephalomyocarditis virus strains isolated in China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Serologic responses of Barbary sheep (Ammotragus lervia), Indian antelope (Antilope cervicapra), wallaroos (Macropus robustus), and chimpanzees (Pan troglodytes) to an inactivated encephalomyocarditis virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.027

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.11.027

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40030262&oldid=1965419220"